Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Stereotaxis, Inc.
Daniel Louis Kaufman filed a Schedule 13G report regarding Stereotaxis, Inc. on August 19, 2026. This filing discloses the beneficial ownership status of the investor, and shareholders should monitor how this stake impacts future corporate governance and stock performance.…more
Stereotaxis, Inc.
Stereotaxis, Inc. filed its 10-Q quarterly report for the period ending June 30, 2026. As of June 30, 2026, the company reported cash and cash equivalents of $10.491 million and total assets of $55.582 million.…more
Stereotaxis, Inc.
스테레오택시스는 2026년 2분기 매출 770만 달러, 순손실 446만 달러(주당순손실 0.05달러)를 기록했습니다. 로보캐스(Robocath) 인수를 완료하고 로봇 카테터 매출이 전 분기 대비 270% 성장했으나, 시스템 매출 감소로 인해 전년 동기 대비 손실 폭이 확대되었습니다.…more
2 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Stereotaxis Installs First Robotic Magnetic Navigation System in Latvia…more
Stereotaxis has installed its Genesis Robotic Magnetic Navigation System at Pauls Stradiņš Clinical University Hospital in Latvia. This installation establishes the country's first robotic center for treating cardiac arrhythmias and has already been used in successful patient procedures.…more
●●●●●●●● ●●●●● ●●●●●●
Stereotaxis will release its financial results for the third quarter of 2026 on November 10, 2026, after the market closes. The company will host a conference call to discuss the results and corporate developments.…more
●●●●●●●● ●●●●● ●●●●●●
Stereotaxis will present its digital and robotic automation technologies at the upcoming HRX 2026 conference. While the company will discuss the potential of autonomous surgical systems, the announcement lacks immediate financial impact, warranting a neutral outlook.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.